Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in Chile

NCT05494047 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1600

Enrollment

OTHER

Sponsor class

Conditions

Influenza
Vaccines

Interventions

DRUG: Tetravalent influenza vaccine developed by Sinovac Biotech Co.

Sponsor

Pontificia Universidad Catolica de Chile

Collaborators

[object Object]
[object Object]